You are here

Article Text

Article menu

Download PDFPDF

Editorial
Rheumatology gone global
Free
  1. Daniel H Solomon1,
  2. Alan Tyndall2,
  3. Sherine E Gabriel3,
  4. Maxime Dougados4
  1. 1
    Division of Rheumatology, Immunology, and Allergy, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA
  2. 2
    Department of Rheumatology, University of Basel, Basel, Switzerland
  3. 3
    Department of Health Sciences Research, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA
  4. 4
    Paris-Descartes University, Medicine Faculty; Cochin Hospital, Rheumatology B Department, Paris, France
  1. Daniel H Solomon, Division of Rheumatology, Brigham and Women’s Hospital, 75 Francis Street, Boston, Massachusetts, 02115, USA; dhsolomon{at}partners.org

https://doi.org/10.1136/ard.2008.095935

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We read about the effects of globalisation everyday in the pages of our newspapers; now read about them here in the pages of your rheumatology journal—the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR) have agreed to collaborate.

    The two organisations have been discussing collaboration for over 3 years and in this issue of both the Annals of the Rheumatic Diseases and Arthritis & Rheumatism (Arthritis Care & Research), the first fruits of that collaboration are blossoming. Aletaha and colleagues from Europe and North America have developed recommendations on reporting disease activity in clinical trials of patients with rheumatoid arthritis (RA), and this paper (as well as this Editorial) is published simultaneously in the two journals (see …

    View Full Text

    Linked Articles

    • Recommendations
      Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations
      D Aletaha R Landewe T Karonitsch J Bathon M Boers C Bombardier S Bombardieri H Choi B Combe M Dougados P Emery J Gomez-Reino E Keystone G Koch T K Kvien E Martin-Mola M Matucci-Cerinic K Michaud J O’Dell H Paulus T Pincus P Richards L Simon J Siegel J S Smolen T Sokka V Strand P Tugwell D van der Heijde P van Riel S Vlad R van Vollenhoven M Ward M Weinblatt G Wells B White F Wolfe B Zhang A Zink D Felson
      Annals of the Rheumatic Diseases 2008; 67 1360-1364 Published Online First: 12 Sep 2008. doi: 10.1136/ard.2008.091454